Survodutide

Survodutide is a dual GLP-1/glucagon receptor agonist studied for its potential in weight management and metabolic disease.

• May support significant reductions in body weight
• Studied for improvements in lipid metabolism and liver fat
• Research explores its role in cardiometabolic health
• Potential benefits in appetite regulation and glycemic control

For research purposes only. Not intended for human consumption, veterinary use, or any purpose other than in vitro scientific research. These statements have not been evaluated by the FDA.